Statement of Principles concerning ulnar neuropathy at the elbow (Balance of Probabilities) (No. 66 of 2017)

The instrument operates by defining a medical entity and then specifying factual antecedents or exposures that, if proved and related to relevant service, the RMA regards as satisfying a causal link on the balance of probabilities.

Defined condition: Ulnar neuropathy at the elbow is defined for the SOP’s purpose as an acquired persistent disturbance of function of the ulnar nerve in the elbow region, present together with (a) altered sensation, pain or weakness in the ulnar nerve distribution, and (b) electrodiagnostic evidence confirming impaired ulnar nerve conduction across the elbow (s6(2)). The requirement of electrodiagnostic confirmation is a threshold evidentiary concept: the SOP does not treat subjective symptoms alone as sufficient.

Death: The SOP explicitly extends to death from ulnar neuropathy at the elbow where the terminal event or condition was contributed to by that neuropathy (s6(3)). The Schedule defines terminal event with examples such as pneumonia and respiratory failure (Schedule 1, terminal event).

Balance of probabilities and medical-scientific basis: The RMA’s statutory task is to determine SOPs that identify on medical-scientific grounds the circumstances in which a condition can be connected to service. The instrument states the RMA is of the view, on the sound medical‑scientific evidence available, that it is more probable than not that ulnar neuropathy at the elbow can be related to relevant service (s7). That expresses the standard and the evidential basis relied on by the RMA in issuing the SOP.

Factors and thresholds: Section 8 is the operative listing of factors. The SOP requires that at least one of the listed factors exist before a finding of connection to service can be made. The factors are precise and often quantitative. Examples include:

• Fracture of bones of the affected elbow before clinical onset (s8(1)).

• A specified discrete trauma to the affected elbow within one year before clinical onset (s8(2)), where trauma is defined with a multi-element test in the Schedule (Schedule 1, trauma to the affected elbow).

• Repetitive and forceful activities involving flexion and extension of the elbow for a cumulative period of at least 90 hours within a continuous three‑month period prior to clinical onset, and where activities have not ceased more than 30 days before onset (s8(3)(a)-(b)). The SOP gives examples of such activities in the note to s8(3).

• Daily self-propulsion of a manual wheelchair for at least 60 cumulative hours within a continuous three‑month period before onset, again not ceased more than 30 days before onset (s8(7)).

• Using elbow or forearm crutches for at least 60 cumulative hours within a continuous three‑month period before onset (s8(9)).

• Hospitalisation or bed confinement in a supine position for at least two days within the two weeks before onset (s8(6)).

• Surgical procedures , either under general anaesthesia within one month prior to onset (s8(4)), or surgery to the elbow within six months prior to onset (s8(5)).

Other medical conditions: The Schedule lists specific comorbid conditions or pathologies that count as factors, for example amyloidosis (s8(11)), acromegaly (s8(16) and Schedule 1), a lesion that compresses or displaces the ulnar nerve (s8(15)), infection of the ulnar nerve region (s8(14)), inflammatory or degenerative joint disease involving the elbow drawn from a specified list (s8(10); Schedule 1).

Onset versus worsening: The SOP distinguishes between factors before clinical onset (s8(1)-(16)) and factors that materially contribute to or aggravate established ulnar neuropathy (s8(17)-(33)). Section 9(2) clarifies that the latter group applies only where the person’s ulnar neuropathy was suffered or contracted before or during, but did not arise out of, the relevant service. That is, those factors are relevant to material contribution or aggravation claims.

Cross-application to other SOPs: Section 10 provides that if a factor in s8 refers to an injury or disease that has its own SOP, the other SOP governs according to its terms. The Schedule also defines terms (e.g. lesion as specified) which are used in the factors.

Evidentiary implications: The SOP imposes concrete evidentiary expectations such as electrodiagnostic confirmation (s6(2)(b)), recorded timing of activities or exposures (cumulative hours and windows in s8), and documented medical diagnoses or operations. The Schedule’s trauma definition adds procedural elements for proving traumatic events: discrete event, symptoms within 24 hours, persistence of symptoms for at least seven days, or medical intervention such as immobilisation, corticosteroid injection, or surgery (Schedule 1, trauma to the affected elbow).

Amendment mechanism: The compilation shows the SOP has been amended since first made (Endnotes). The amendment history records a 2020 amendment to the trauma definition (Endnote 4). The RMA may re-determine SOPs on medical-scientific grounds per its statutory role; this instrument reflects those determinations at the stated compilation date.

Primary subjects: The SOP explicitly applies to claims to which s120B of the VEA or s339 of the MRCA applies (s4). That means persons who present claims under those statutory provisions that require a medical causation finding will be affected. The Schedule defines relevant service to include eligible war service (other than operational service), defence service (other than hazardous service and British nuclear test defence service) under the VEA, or peacetime service under the MRCA (Schedule 1, relevant service). The instrument is therefore addressed to veterans and members of the Forces whose service falls within those definitions and who lodge claims concerning ulnar neuropathy at the elbow.

Decision-makers and administrators: The SOP is determined by the Repatriation Medical Authority (s3), but the instrument does not itself adjudicate claims. It provides the medical causation framework that will be used by decision-makers applying the VEA and MRCA causation provisions. The SOP is, therefore, relevant to whatever administrative or judicial decision-maker is called upon by the VEA or MRCA to decide causation in a claim. The text of the SOP does not, however, set out which agency ultimately pays or the procedural steps for making a claim; it is a substantive input into the statutory schemes referenced in s4.

Medical practitioners and experts: Treating clinicians, independent medical examiners and electrodiagnostic specialists are materially affected because the SOP requires specific medical evidence to satisfy the definition of the condition and the connection to service. For example, the SOP requires electrodiagnostic evidence confirming impaired ulnar nerve conduction across the elbow (s6(2)(b)), and refers to diagnoses such as amyloidosis, acromegaly, and inflammatory or degenerative joint diseases that must be appropriately documented (s8(10), s8(11), s8(16); Schedule 1).

Employers and records-holders: The SOP’s quantitative exposure thresholds , cumulative hours over a continuous three-month period for certain repetitive activities (s8(3), s8(19)), or cumulative hours of wheelchair or crutch use (s8(7), s8(9), s8(23), s8(25)) , make contemporaneous records of duties, equipment use and hours materially relevant. Military units, employers, occupational health services, physiotherapists and allied health services that can supply service records, duty rosters and rehabilitation notes may therefore be called upon to provide evidence.

Claimants with comorbid conditions: Persons whose ulnar neuropathy coexists with other upper limb neuropathies or systemic diseases are affected by the SOP’s cross-references and the specified list of conditions. For example, the SOP notes that ulnar neuropathy at the elbow may coexist with carpal tunnel syndrome (s6(2) Note 2), and identifies a list of specific inflammatory and degenerative joint diseases in the Schedule (Schedule 1).

Legal advisers and advocates: Solicitors, barristers, claims advocates and other advisers acting for claimants or for the Respondent in VEA/MRCA matters must build medico-legal submissions that map medical facts and documentary evidence onto the SOP’s requirements. The SOP’s detailed thresholds and definitions will shape evidence strategies and contested issues, such as determining a claimant’s clinical onset date, interpreting the trauma definition, proving cumulative exposure hours, and establishing inability to obtain appropriate clinical management (s8(33)).

In sum, the instrument is not a general duty-imposing statute; it shapes the evidentiary and medical framework used to determine whether ulnar neuropathy at the elbow is connected to relevant service for the discrete purposes of VEA and MRCA claims (s4, s7). The practical effect is to impose on claimants and their representatives a need to marshal the specific types of medical and documentary proof that the RMA has enumerated.

This SOP is not phrased as imposing civil duties or creating private rights in the way primary legislation does. Instead it establishes the medical criteria that decision-makers must take into account when assessing causation under the VEA and MRCA claim pathways cited in s4. The following are the operative legal effects, framed as duties or evidentiary requirements for parties and decision-makers.

Evidentiary duty to show the condition as defined: To rely on the SOP a claimant must establish that the person has ulnar neuropathy at the elbow as defined: an acquired persistent disturbance of ulnar nerve function in the elbow region with altered sensation, pain or weakness in the ulnar distribution, and electrodiagnostic evidence confirming impaired ulnar nerve conduction across the elbow (s6(2)). The requirement of electrodiagnostic confirmation is an explicit evidentiary threshold the SOP imposes as part of the condition’s definition.

Requirement that at least one factor from s8 exists: Section 8 operates as a gate. At least one of the listed factors must exist before it can be said, on the balance of probabilities, that ulnar neuropathy at the elbow or death from it is connected with the circumstances of relevant service. The RMA sets these factors as jurisdictional or probative criteria for causation findings under the VEA/MRCA processes to which s4 refers.

Time and exposure thresholds: Several factors in s8 are quantitative. For repetitive and forceful activities engaging elbow flexion/extension, the SOP requires a cumulative period of at least 90 hours within a continuous period of three months before clinical onset, and that such activities have not ceased more than 30 days before onset (s8(3)(a)-(b)). For manual wheelchair self-propulsion and use of elbow or forearm crutches, the cumulative threshold is 60 hours within a continuous three-month period and subject to the 30-day cessation rule (s8(7), s8(9)). For hospitalisation/bed confinement, the threshold is at least two days within two weeks prior to onset (s8(6)). These thresholds can be seen as duties on claimants to produce evidence sufficient to meet these quantified tests.

Onset and worsening distinction: Sections 8(1)-(16) are expressed in terms of events or exposures before clinical onset. Sections 8(17)-(33) mirror those factors in relation to clinical worsening. Section 9(2) creates an interpretive duty: subsections 8(17)-(33) apply only to material contribution to or aggravation of existing ulnar neuropathy where the condition was suffered or contracted before or during, but did not arise out of, relevant service. Thus, for aggravation claims, a claimant must show pre-existing condition timing as well as the aggravating exposure connected to service.

Cross-application to other SOPs: If a factor in s8 refers to an injury or disease that is the subject of another SOP, that other SOP applies according to its terms (s10). This produces a duty on decision-makers and advisers to identify overlapping SOPs and to apply the relevant SOP mechanism when an element of causation is dependent on a different disease or injury.

Relation to relevant service: Section 9(1) requires that the existence in a person of any factor in s8 must be related to the relevant service rendered by the person. The Schedule defines what counts as relevant service (Schedule 1, relevant service). The SOP thus imposes a connective requirement between the factual factor and the person’s service.

No express private right to remedies in the SOP: The instrument does not itself create payment obligations, entitlements or a right to compensation. It is designed to be used in the adjudication of claims under the referenced statutes. The SOP does not include procedural rights, appeal rights or specify remedies; those remain regulated by the VEA and MRCA processes that the SOP informs (s4).

Undefined or interpretive terms requiring evidentiary proof: Some terms potentially critical to causation are not exhaustively defined. For example, “clinical onset” and “clinical worsening” are used throughout but are not defined in the Schedule. “Inability to obtain appropriate clinical management” is included as a factor (s8(33)) yet not defined. The Schedule’s definition of “trauma to the affected elbow” is detailed and prescriptive; compliance with that definition will require particular forms of contemporaneous medical documentation (Schedule 1, trauma to the affected elbow).

In short, the instrument imposes on claimants the practical duty to produce specific forms of medical and documentary evidence that correspond to the SOP’s diagnostic and causal thresholds. Decision-makers are directed to treat the SOP as determinative of what factors, if shown, satisfy medical causation on the balance of probabilities for the purposes of claims to which it applies.

This Statement of Principles contains no express penalties, criminal offences or administrative fines. It is a determinative instrument setting medical criteria for causation findings. The document itself provides no enforcement or sanctioning provisions. Its enforcement mechanism is functional and indirect: compliance is enforced through the outcomes of claims adjudication under the VEA and MRCA schemes, which use this SOP as an evidentiary and causation framework (s4, s7). The SOP does not specify the procedural steps for claims, who pays benefits, or the sanctions for providing false information; those matters are governed by the enabling Acts and the administrative rules and tribunals that oversee them.

Practical enforcement consequences: While there are no penalties in the SOP, the operational consequences are material. If the requisite factors and the defined condition are not established to the decision-maker’s satisfaction, a claimant’s medical causation may fail, resulting in denial of a claim under the VEA or MRCA processes. Conversely, if factors are established and linked to relevant service, that may support a positive decision. The SOP therefore functions as a determinative evidentiary rule within the broader enforcement and entitlements framework of those Acts.

Scope for evidentiary challenge: The SOP’s reliance on quantitative thresholds, the requirement for electrodiagnostic confirmation, and the Schedule’s detailed trauma definition create identifiable implementation and litigation risks when records are incomplete, ambiguous or equivocal. Disputed cases will turn on whether medical records meet the SOP’s tests. Disagreement will arise over the meaning of “clinical onset” and “clinical worsening,” the sufficiency of electrodiagnostic evidence, whether a discrete traumatic event satisfies the Schedule definition, and whether cumulative hours thresholds for repetitive activities are met. Those are evidentiary disputes resolved in the statutory claim process; the SOP itself provides no internal enforcement mechanism to resolve them.

Administrative implementation: The SOP’s functional enforcement therefore rests with decision-makers applying the VEA and MRCA. The RMA’s determination instructs those decision-makers on what medical factors should be treated as sufficient for causation on the balance of probabilities. The SOP does not itself create review, appeal or sanction pathways; any such enforcement or challenge lies in the administrative and judicial processes provided in the enabling Acts.

Statutory foundation and applicable claims: The SOP is made under subsection 196B(3) of the VEA (s3). It applies to claims falling under section 120B of the VEA or section 339 of the MRCA (s4). The Schedule defines VEA and MRCA (Schedule 1). Thus the SOP interacts directly with the VEA and MRCA: it is an evidentiary instrument that those Acts’ decision-making processes will incorporate in causation assessments.

Relevant service and scope: The Schedule’s definition of relevant service (Schedule 1) cross‑links to the service concepts contained in the VEA and MRCA. The SOP therefore interacts with those Acts’ eligibility rules by restricting the SOP’s application to defined classes of service, namely eligible war service (other than operational service), defence service (other than hazardous service and British nuclear test defence service) under the VEA, and peacetime service under the MRCA (Schedule 1, relevant service).

Cross-references to other Statements of Principles: Section 10 directs that where a factor in s8 refers to an injury or disease that is the subject of another Statement of Principles under subsection 196B(3) of the VEA, that other SOP applies according to its terms as in force from time to time. This creates an inter‑instrument hierarchy and a requirement to identify and apply relevant SOPs in a coordinated manner. For example, if s8 refers to an inflammatory arthritis that itself has an SOP, the assessment of that factor must be carried out under the terms of that other SOP.

Evidentiary and medical standards versus civil liability regimes: The SOP sets a medical causation standard for administrative claims. It does not displace or define causation standards in other legal regimes such as workers’ compensation, common law negligence claims, or civil compensation schemes outside the VEA/MRCA remit. The SOP is a specialised instrument for the veterans’ compensation context; absent express incorporation, it does not directly govern evidentiary standards in other tribunals or courts.

Interaction with clinical practice and professional standards: By requiring electrodiagnostic evidence and specifying timing and exposure thresholds, the SOP effectively prescribes the kinds of clinical documentation that will be determinative in the statutory scheme. Clinicians treating veterans or serving members may therefore be required by professional protocol or by litigation to provide reports and test results that align with the SOP’s requirements. However the SOP does not itself regulate clinical practice or professional disciplinary standards.

Amendment and temporal interaction: The compilation shows the SOP can be and has been amended (Endnotes). The SOP’s terms apply “as in force from time to time” when interacting with other SOPs (s10). Practitioners must therefore monitor amendment history for changes that affect definitions or thresholds, such as the 2020 amendment to the trauma definition recorded in the endnotes (Endnote 4).

No express displacement of general medical evidence: The SOP identifies specific factors and medical tests that are determinative for the purposes of the VEA/MRCA. It does not state that other evidence is irrelevant, but the RMA’s approach is to identify the circumstances in which the RMA is of the view that a condition can be related to service on the balance of probabilities (s7). Decision-makers applying the VEA and MRCA will use the SOP as the primary medical framework, which may narrow the practical scope of acceptable proof compared with a purely clinical causation assessment.

In short, the SOP sits as a specialised medical-evidentiary instrument within the VEA/MRCA legal architecture. It cross-references and can be cross-applied to other SOPs. It does not itself change criminal, tort or workers’ compensation law, but it directly informs causation findings for claims under the VEA and MRCA.

The compilation includes information showing the SOP’s legislative history and recorded amendments up to the compilation date. Key dates recorded in the instrument are:

• Determination date: The Repatriation Medical Authority determined this SOP on 3 November 2017; the instrument commenced on 4 December 2017 (s2; front matter).

• Compilation date and amendment: This is Compilation No. 1 with compilation date 25 May 2020. The compilation includes an amendment instrument titled Amendment Statement of Principles concerning ulnar neuropathy at the elbow (No. 45 of 2020), registered 28 April 2020, with commencement 25 May 2020 (Endnote 3). The compilation notes that the day of commencement of that amendment was 25 May 2020 (front matter).

• Nature of amendment: Endnote 4,Amendment history records that Schedule 1 - Dictionary - trauma to the affected elbow was amended by rs. No. 45 of 2020. The endnotes indicate that misdescribed amendments are noted where they occur; here the amendment is recorded with a reference number and date (Endnote 4).

What the amendment changed: The compilation does not reproduce the prior text of the trauma definition, but the amendment history explicitly records that the Schedule 1 definition of “trauma to the affected elbow” was replaced or revised by the 2020 instrument (Endnote 4). The current compiled text of Schedule 1 contains a detailed multi-part definition of trauma to the affected elbow, specifying the discrete event, symptom onset within 24 hours (or on return to consciousness/withdrawal of analgesics), persistence of symptoms for at least seven days unless medical intervention occurred, and examples of such interventions (Schedule 1, trauma to the affected elbow). The amendment therefore materially tightened or clarified the evidentiary elements required to show a traumatic event.

Implications of amendment timing: Practitioners should note that the SOP’s operative text changed in 2020, and the compiled version includes that amendment. For claims with events falling before the amendment commenced, decision-makers may need to consider the temporal application of amendments under the rules of the VEA and MRCA. The instrument’s front matter and endnotes flag that uncommenced amendments are not shown and that details are included in the endnotes; they also point to the Legislation Register for full amendment detail. The SOP records the amendment but does not include transitional or savings provisions in the text; any such provisions would be found in the amending instrument or the enabling Acts and are not reproduced in the SOP itself.

Absence of further amendments in compilation: The endnotes list only the original SOP (No. 66 of 2017) and the 2020 amending SOP (No. 45 of 2020) in the legislation history (Endnote 3). The amendment history table in Endnote 4 records the Schedule 1 trauma amendment as the affecting item.

Practical consequence for advisers: Because the trauma definition is both central to some factors in s8 and explicitly amended in 2020, practitioners should verify the date of the alleged trauma and ensure they are relying on the correct version of the definition as in force at the relevant time. The SOP, as compiled, reflects the post-amendment definition for decisions made after the 25 May 2020 commencement.

The compiled instrument contains no record of judicial decisions or litigation references. The SOP itself does not list cases, and the endnotes do not record any litigation that interprets this particular Statement of Principles. The document is a medical‑scientific determinative text used in administrative decision-making rather than a court judgment. The RMA’s text does not cite any cases as part of its determination.

Implication for practitioners: The absence of litigation history in the instrument means there is no recorded body of case law within the SOP compilation to aid in interpretation of its terms. Practitioners therefore should treat the SOP’s text as the primary source of interpretive guidance on the medical and factual criteria it sets out and anticipate that contested points,such as the meaning of “clinical onset,” the sufficiency of electrodiagnostic testing, the application of the trauma definition, or what constitutes “inability to obtain appropriate clinical management” (s8(33)),may be litigated in individual claim contexts where administrative decisions are subject to review. Any such litigation and resulting jurisprudence will appear in tribunal or court reports rather than within the SOP compilation.

Where litigation exists outside the SOP: The SOP cross-references other SOPs and the underlying VEA and MRCA. There may be litigation on those statutes’ causation provisions or on other SOPs that inform how factors are applied. Such litigation is not recorded here. Practitioners should therefore review tribunal and court decisions interpreting the application of SOPs in VEA/MRCA claims generally when advising on likely evidentiary outcomes, even though the SOP compilation itself does not identify such cases.

Expectation of contested evidentiary issues: Given the SOP’s reliance on medical testing and quantified exposure thresholds, common litigation focal points will likely include the adequacy and interpretation of electrodiagnostic evidence, the timing of clinical onset and worsening, the sufficiency of documentary proof for cumulative exposure thresholds, and the application of the trauma definition where records are incomplete. These are predictable litigation vectors even if the compilation itself lists no authorities.

A number of specific pitfalls arise from the SOP’s formulation; these are practical, text‑based risks that claimants and advisers must manage.

Electrodiagnostic requirement is mandatory in definition: The SOP defines ulnar neuropathy at the elbow to include electrodiagnostic evidence confirming impaired ulnar nerve conduction across the elbow (s6(2)(b)). The corollary is that subjective symptom reports without electrodiagnostic confirmation will not, on the face of the SOP, meet the condition definition. Practitioners should ensure electrodiagnostic studies are arranged and reported in a form that addresses conduction across the elbow specifically.

Unclear definition of clinical onset and clinical worsening: The SOP uses these timing anchors repeatedly in s8 but does not define them in the Schedule. That leaves room for dispute over when an episode began or when worsening occurred. Contemporaneous clinical notes that record first symptoms, dates of presentation and first positive tests will be critical. Absent clear contemporaneous documentation, claimants may fail to meet the temporal windows the SOP requires.

Strict temporal windows and cessation rules: Several factors require that the exposure or activity has not ceased more than 30 days before clinical onset or worsening (see s8(3)(b), s8(7)(b), s8(9)(b), and corresponding worsening subsections). This 30-day rule can be dispositive. Counsel should map claimed activities against this window and obtain service records, duty rosters or treatment notes that demonstrate continuity of exposure up to the relevant time.

Cumulative hours thresholds require contemporaneous evidence: Repetitive and forceful activities must total at least 90 hours within a continuous three-month period (s8(3)(a)). Wheelchair or crutch use requires 60 cumulative hours within a continuous three-month period (s8(7)(a), s8(9)(a)). Post-hoc estimates by claimants are weaker than contemporaneous duty or therapy logs, and may not persuade decision-makers. Employers, unit records, physical therapy notes, rehabilitation plans and diary entries are crucial.

Trauma definition is multi-element and was amended: The Schedule definition of trauma to the affected elbow requires a discrete event applying significant force, symptom development within 24 hours (or on return to consciousness/withdrawal of analgesics), persistence for at least seven days unless specific medical interventions occurred, and examples of interventions that will satisfy the alternative persistence requirement (Schedule 1). Following the 2020 amendment, practitioners must ensure trauma narratives and medical records explicitly address each element. Cases where symptoms were masked by analgesics or unconsciousness require documentation of symptom appearance when analgesic effects ended or consciousness returned.

Surgical and anaesthesia timing windows are short: A surgical procedure under general anaesthesia within one month before clinical onset (s8(4)) or elbow surgery within six months before onset (s8(5)) are recognised factors. Practitioners must obtain operative notes and anaesthesia records to show dates and that the procedure preceded onset.

Hospitalisation and supine confinement: The SOP treats hospitalisation or bed confinement in supine position for at least two days within two weeks before onset as a factor (s8(6)). Clinical records must document the posture and dates. Generic hospital discharge summaries that do not specify bedbound supine position or duration may be insufficient.

‘Lesion as specified’ is broad but must be evidenced: Schedule 1 lists many possible lesions including neoplasms, bony fragments, calcification, cysts, ganglia, gouty tophi, haemorrhage, scar, tuberculoma and others. Imaging, surgical notes and histopathology will be necessary to prove such lesions compressing or displacing the ulnar nerve (s8(15,31)).

Coexisting conditions and cross-application to other SOPs: Some factors refer to other diseases that themselves may be the subject of other SOPs. Section 10 requires applying those SOPs “in accordance with the terms of that Statement of Principles”. Practitioners must identify whether a factor is governed by another SOP and build evidence accordingly.

‘Inability to obtain appropriate clinical management’ is undefined: Section 8(33) includes inability to obtain appropriate clinical management as a factor but does not define it. That invites dispute over what attempts and barriers constitute an inability. Contemporaneous correspondence, appointment attempts, specialist referrals, waitlists, and explanations of systemic barriers will be essential evidence, but the SOP’s silence on definition makes outcome uncertain.

Difference between onset and aggravation claims: Subsections 8(17)-(33) are limited to aggravation claims and, per s9(2), only apply where the person’s ulnar neuropathy was suffered or contracted before or during, but did not arise out of, relevant service. Advisers must therefore clearly identify whether the claim is for first occurrence linked to service or for material contribution/aggravation of a pre-existing condition and select factors accordingly.

Death connection requires contribution to a terminal event: Section 6(3) extends the SOP to death where a terminal event or condition was contributed to by ulnar neuropathy. The Schedule lists example terminal events but practitioners must show contribution, which is often a complex medical causation question requiring expert evidence linking the neuropathy to the proximate cause of death.

No penalties or procedures in the SOP: The instrument does not set procedural timelines, appeal rights, or evidence admission rules. Those remain in the VEA and MRCA. Practitioners should therefore coordinate SOP evidence with the procedural requirements and evidentiary rules of the enabling Acts.

Collect these gotchas early and document them meticulously in claim preparation to avoid having an otherwise meritorious medical case fail for want of the specific types of proof the SOP requires.

To prepare an effective claim under the VEA or MRCA where this SOP applies, adopt a structured evidentiary plan that maps the SOP’s elements (s6, s8, Schedule 1) to documentary and expert evidence. The following practical steps flow directly from the SOP text and the definitions in the Schedule.

1. Establish the medical diagnosis as defined

• Obtain a contemporary clinical diagnosis describing ulnar neuropathy at the elbow, including documentation of altered sensation, pain or weakness in the ulnar distribution (s6(2)(a)).
• Procure electrodiagnostic testing (nerve conduction studies and electromyography) that explicitly addresses conduction across the elbow, with the expert report stating impaired ulnar nerve conduction across the elbow (s6(2)(b)). Ensure testing protocols and normative values are included.

2. Fix the clinical onset and any clinical worsening dates

• Search clinical records, primary care notes, emergency department notes and specialist consults for the earliest recorded symptom report and for any recorded deterioration. Because the SOP repeatedly uses “clinical onset” and “clinical worsening” as timing anchors (s8), contemporaneous entries are valuable.
• Where symptoms were masked by analgesia or unconsciousness, ensure records show dates of return to consciousness or withdrawal of analgesia and the onset of symptoms thereafter in accordance with the trauma definition (Schedule 1, trauma to the affected elbow).

3. Match facts to s8 factors precisely

• If relying on fracture, trauma, or lesion factors (s8(1), s8(2), s8(15)), obtain imaging, operative reports, emergency department records, and contemporaneous treatment notes. For trauma claims, ensure that the medical records document the discrete event, the timing of symptom development within 24 hours, and persistence for at least seven days or document the relevant medical intervention types listed in the Schedule (Schedule 1).
• For repetitive and forceful activity claims (s8(3), s8(19)), assemble duty statements, rosters, training logs, after-action reports, unit diaries, occupational histories, or sworn affidavits that quantify hours. The SOP requires 90 cumulative hours within three continuous months and that the activity not have ceased more than 30 days prior to onset (s8(3)(a)-(b)).
• For manual wheelchair or crutch use (s8(7), s8(9)), get physiotherapy notes, rehabilitation plans and attendant records showing daily self-propulsion or crutch use and quantifying cumulative hours over the three-month window. Create or obtain contemporaneous assistive device usage logs if possible.
• For surgery and anaesthetic factors (s8(4), s8(5)), obtain anaesthetic records, operation notes, theatre logs and peri-operative notes that show dates and anaesthesia type.
• For hospitalisation/supine bed factors (s8(6)), obtain inpatient nursing notes, physiotherapy documentation and ward records indicating posture and duration.

4. For comorbid disease factors, get definitive diagnoses

• If amyloidosis, acromegaly or a listed inflammatory/degenerative joint disease is asserted (s8(11), s8(16), s8(10)), obtain specialist reports, pathology, biochemical testing, imaging and management records that meet accepted diagnostic criteria. Ensure the disease documentation specifically notes involvement of the affected elbow where required.
• For lesion as specified (s8(15), s8(31)), obtain imaging (MRI, CT, ultrasound), surgical notes, histopathology, or biopsy reports that show the lesion compresses or displaces the ulnar nerve.

5. Prove linkage to relevant service

• Because s9(1) requires that any factor relied upon be related to the person’s relevant service, gather service records, deployment documents, duty allocations, training records and unit statements that link the timing and location of the exposure to the claimant’s relevant service as defined in the Schedule (Schedule 1, relevant service).

6. For aggravation claims, establish pre-existing condition timing

• For factors in subsections 8(17)-(33) (material contribution or aggravation), ensure the claimant’s ulnar neuropathy pre-dated or occurred during relevant service but did not arise out of service (s9(2)). Provide pre-service or in-service medical records showing the pre-existing condition where applicable.

7. Address “inability to obtain appropriate clinical management” carefully

• If relying on s8(33), document attempts to access care: referrals, appointment requests, specialist wait times, correspondence, travel barriers, or systems-based impediments. Since the SOP does not define the term, contemporaneous evidence of failed attempts to obtain appropriate management will be persuasive.

8. Use expert medico-legal reports that map facts to SOP criteria

• Commission medical experts to opine explicitly on whether the SOP’s medical and temporal thresholds are met. Experts should address electrodiagnostic results, whether cumulative exposure thresholds are met, whether trauma satisfies the Schedule test, and whether the claimed factor is related to relevant service (s6, s8, Schedule 1). Experts should express causation using the language of the SOP (for example, whether the specified factor “more probably than not” connects the condition to service).

9. Anticipate cross-application to other SOPs

• Identify whether any factor invokes another SOP (s10). If so, obtain and apply the other SOP’s terms and ensure the evidence meets any additional tests required by that SOP.

10. Maintain chain-of-evidence and contemporaneous documentation

• The SOP’s precise thresholds make retrospective reconstructions vulnerable. Ensure records are complete, dated and signed. Where records are sparse, contemporaneous affidavits explaining why records are missing and corroborative third-party statements (unit members, supervisors, therapists) may assist, but they are generally weaker than contemporaneous clinical or service documents.

11. Monitor amendments and applicable version dates

• Verify which version of the SOP and its definitions applies to the claim event date. The trauma definition, for example, was amended with effect from 25 May 2020 (Endnote 3; Endnote 4). Where timing is close to amendments, consider whether transitional provisions apply under the enabling Acts or amending instruments.

12. Prepare submission mapping SOP elements to statutory claim elements

• Build claim submissions that identify the statutory claim pathway (s120B VEA or s339 MRCA), present the SOP elements satisfied with precise citations to s6 and s8, include expert opinions stating the condition meets the SOP definition and that at least one factor is present and linked to relevant service, and attach the underlying documentary proof.

Compliance in practice therefore means aligning medical proof and factual documentation to the SOP’s specified elements and thresholds. Because the SOP is an evidentiary standard for VEA/MRCA claims, meticulous documentation and tightly focused expert opinion that mirror the SOP language are the practical means of adherence.